Current Challenges & Successes in Fighting Viruses

05/12/2020
00:58:43
Current Challenges & Successes in Fighting Viruses

Current Challenges & Successes in Fighting Viruses

Vaccines are a first line of defense in preventing viral illnesses, but once diagnosed what are possible next steps? With new viruses such as SARS-CoV-2 –which causes COVID-19, what can be realistic timelines to develop potential new vaccines and treatments? What challenges have we seen in providing solutions with other viruses and how can we use that knowledge to combat future strains? Join us for a talk with several leading scientists as we discuss the challenges and success in the virus battle today and as we prepare for the future.

*This program is a product of a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.
 

Check out more On-Demand Webinars

The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only.  This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates.  The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.


Related content

TAGS